Alcohol-Related Liver Disease Increases Sharply
Those most likely to be heavy drinkers are women, adults aged 45 years or older, those living in poverty, and those with metabolic syndrome, the data showed.
'Alcohol-related liver disease is the main cause of liver-related death, and these results are a major wake-up call to the dangers of drinking,' lead investigator Brian Lee, MD, MAS, hepatologist and liver transplant specialist with Keck Medicine of University of Southern California, Los Angeles, said in a statement.
The study was published online on July 23 in Clinical Gastroenterology and Hepatology .
Call for Increased Awareness
To gauge trends in advanced alcohol-related liver disease among heavy drinkers, Lee and colleagues mined data from the National Health and Nutrition Examination Survey (NHANES) spanning 1999-2020.
The primary outcome was a high Fibrosis-4 (FIB-4) score (FIB-4 > 2.67 for those aged 65 years or younger and > 3.25 for those older than 65 years), which has previously been linked to a 25-fold higher risk for liver-related death. People with hepatitis B or C were excluded.
Among 44,628 adults, 2474 were heavy drinkers — defined as at least 20 g/d for women and 30 g/d for men in the prior year.
Among heavy drinkers, the prevalence of high FIB-4 — a marker of advanced liver scarring — increased more than twofold over time, from 1.8% in 1999-2004 to 4.3% in 2013-2020, vs an increase of 0.8%-1.4% among non-heavy drinkers.
Notably, average alcohol intake stayed the same during the study period, the researchers said.
Among heavy drinkers, the prevalence of metabolic syndrome rose from 26.4% in 1999-2004 to 37.6% in 2013-2020, the mean age increased, and a greater proportion was women or living in poverty — factors that can amplify susceptibility to alcohol's liver effects.
Supplementary analyses restricting the cohort to adults aged 35-65 years or to pre-pandemic years (1999-2018) confirmed the same upward trends, with significant liver scarring tripling over 20 years.
Limitations cited by the authors include the cross-sectional design of NHANES and reliance on self-reported alcohol intake, which can't capture fluctuations over time, and the use of FIB-4 as a surrogate for liver disease.
Collectively, the data suggest that increasing morbidity and mortality due to alcohol-related liver disease 'may be related to a population more sensitized to the alcohol-related effects in the liver due to increased baseline risk factors,' the researchers wrote.
The findings provide impetus for 'urgent awareness' of the contemporaneous risk for alcohol-related liver disease with heavy drinking and interventions to screen and treat risk factors, they added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a few seconds ago
- Yahoo
AI in Telehealth & Telemedicine Market worth $27.14 Billion by 2030 with 36.4% CAGR
DELRAY BEACH, Fla., July 29, 2025 /PRNewswire/ -- The global AI in Telehealth & Telemedicine Market, valued at US$2.85 billion in 2023 stood at US$4.22 billion in 2024 and is projected to advance at a resilient CAGR of 36.4% from 2024 to 2030, culminating in a forecasted valuation of US$27.14 billion by the end of the period. The market has experienced significant growth primarily driven by the growing geriatric and medically underserved (predominantly rural) population, the increasing prevalence of chronic conditions, the shortage of physicians and care personnel, advancements in telecommunication technologies, and the expansion of RPM systems. However, the growing use of wearables, apps, and sensors for virtual care, the increasing shift towards outpatient care models, and the high utility of telemedicine against infectious diseases and epidemics are significant opportunities in the market. Download PDF Brochure: Browse in-depth TOC on "AI in Telehealth & Telemedicine Market" 409 - Tables58 - Figures380 - Pages By application, the primary care segment commanded the most significant proportion of the AI in telemedicine market due to an increased need for day-to-day healthcare, such as check-ups, chronic condition management, and preventive care, well-suited for AI implementation. These platforms leverage AI to automate symptom evaluation, virtual consultations, and follow-ups to make healthcare more accessible and convenient for day-to-day health issues. Organizations such as Hellocare (US) provide a complete telehealth platform with AI-based solutions for primary care, including virtual patient observation and RPM. These solutions increase patient engagement and simplify care delivery. Furthermore, CVS Health (US) provides CVS Health Virtual Primary Care by providing personalized digital healthcare services, enabling users to access and manage their health remotely. By function, the remote patient monitoring segment is expected to be the fastest-growing segment of AI in telehealth market by function due to the increasing number of chronic diseases (including diabetes, hypertension, and CVDs) that need constant monitoring and management. RPM systems constantly monitor patient health data, eliminating the need for many hospital visits and improving patient outcomes. Many healthcare facilities, such as Mayo Clinic (US), offer RPM systems to reduce readmission rates. In January 2025, Taiwan's Industrial Technology Research Institute (ITRI) introduced AI-based RPM devices that were developed in partnership with StreamTeck (Taiwan) to detect patient vitals (body temperature, heart rate, and blood pressure). By geography, North America accounted for the largest market share due to the region's modern healthcare infrastructure, the widespread use of advanced technologies, and extensive governmental support. The US, especially, has adopted favorable reimbursement policies and regulatory mandates, including those from the Centers for Medicare & Medicaid Services (CMS), to increase telehealth access and RPM technology. Favorable government initiatives have also propelled market growth. In October 2023, the American Telemedicine Association published a new AI principle to advance the safe, appropriate, and responsible use of AI in healthcare that enhances patient and provider trust, safety, and the efficacy of AI adoption as a tool in healthcare. Numerous US-based companies provide AI-based telehealth & telemedicine solutions—in October 2024, Zoom Communications (US) partnered with Suki AI, Inc. (US) to implement AI-powered voice tools within their telehealth services to improve clinical documentation functionalities. Together, these factors enhance North America's leadership in the AI in telehealth & telemedicine market. Request Sample Pages : Prominent players in the telehealth & telemedicine market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Epic Systems Corporation (US), Oracle (US), Doximity, Inc. (US), Teladoc Health, Inc. (US), American Well (US), Siemens Healthineers AG (Germany), and Cisco Systems Inc. (US), among others. Koninklijke Philips N.V (Netherlands) Koninklijke Philips N.V. is a diversified technology-based company in the AI in telehealth markets. It is one of the leading companies in the healthcare sector with a strong presence in cardiac care, acute care, and home healthcare. The company operates through four segments: Personal Health, Diagnosis & Treatment, Connected Care, and Others. The AI-based telehealth & telemedicine services fall under the Connected Care segment. The Connected Care segment comprises Business Monitoring, Sleep & Respiratory Care, and Enterprise Informatics. Providers and patients use telehealth solutions. The company operates in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In November 2024, Philips received FDA approval for remote scanning and protocol management features in its Radiology Operations Command Center (ROCC), allowing radiologists to assist with scans remotely. Medtronic (Ireland) Medtronic (Ireland) is one of the largest medical technology, services, and solutions companies. The company operates through four principal segments: Cardiovascular, Diabetes, Medical Surgical, and Neuroscience. The company provides AI-based telemedicine solutions across all four segments. The Cardiac and Vascular segment offers products and services to diagnose, treat, and manage cardiac rhythm disorders and CVDs. Medtronic's portfolio encompasses RPM platforms and patient-centered software through its products and Medtronic Care Management Services. The telehealth solutions offered by the company cover glucose management and cardiac condition management. Medtronic's telehealth device offerings include Bluetooth-enabled and direct-connect peripherals. These devices comprise weight scales, glucometers, blood pressure monitors, pulse oximeters, pedometers, and activity trackers. Medtronic serves its customers in ~160 countries worldwide. The company operates in North America, Latin America, Europe, the Asia Pacific, the Middle East & Africa, and Russia. Epic Systems Corporation (US) Epic Systems Corporation (US) is a software development, installation, and support company that provides consulting services. The company establishes healthcare management software that combines financial and clinical information from inpatient, ambulatory, and payer technology systems. The company's core competency is to provide EHR software solutions. Epic Systems Corporation integrates AI into telehealth & telemedicine through strategic partnerships with Microsoft and Gen AI technologies. Epic improves productivity and patient care in virtual healthcare by combining its EHR solutions with Microsoft's Azure OpenAl Service. It encompasses improving workflows, enabling generative Al to compose message responses, and supporting natural language queries. Epic's AI efforts also enhance self-service reporting tools, maintain financial integrity, and improve clinical outcomes, all of which will enhance global telehealth & telemedicine systems. It operates its offices in the US, the UK, Canada, Denmark, the Netherlands, Norway, Saudi Arabia, the UAE, Finland, Ireland, Australia, Singapore, and Switzerland. For more information, Inquire Now! Related Reports: Telehealth & Telemedicine Market Home Healthcare Market Healthcare IT Market Remote Patient Monitoring (RPM) Market IoT Medical Devices Market Get access to the latest updates on AI in Telehealth & Telemedicine Companies and AI in Telehealth & Telemedicine Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets
CNN
3 minutes ago
- CNN
US to burn $9.7 million worth of USAID-purchased contraceptives rather than deliver them to women overseas
The Trump administration is set to destroy $9.7 million worth of US-purchased contraceptives rather than deliver them to women overseas, following the dismantling of foreign assistance programs carried out by the US Agency for International Development, or USAID. The 'preliminary decision' to destroy the USAID-procured birth control was confirmed by a State Department spokesperson, who said the cost of incinerating them would be $167,000. The contraceptives have been housed in a warehouse in Geel, Belgium. The Belgian foreign ministry said it was engaged in diplomatic talks with the US embassy to work to find alternative solutions for the supplies. The contraceptives are mostly long-lasting types of birth control, such as intrauterine devices (IUDs) and injectables, a US congressional aide told CNN. It is not clear exactly when the supplies will be destroyed, according to the aide. 'They have to double incinerate the products because they contain high levels of hormones and they don't want to risk leaking the byproducts out in the environment, which likely adds to the cost,' the congressional aide said. 'The Trump administration is quite literally burning taxpayer money.' A list of the supplies, shared with CNN by another source with knowledge of the warehouse stock, shows that the contraceptives include copper IUDs, rod implants, birth control injections, and levonorgestrel and ethinyl estradiol tablets. Some have USAID branding but the majority do not, according to the source's list. Most of the products expire in 2028 or 2029, with the earliest expiration date among the products in April 2027, according to the list detailing the nearly 5 million items. The US State Department spokesperson referred to the contraceptives to be destroyed as 'certain abortifacient birth control commodities from terminated Biden-era USAID contracts.' There is controversy about whether to describe certain contraceptives as abortifacient, or causing abortion, due to the debate over whether life begins at the moment an egg is fertilized or at a later stage. Some birth control methods, including IUDs, may work by preventing implantation of a fertilized egg. However, IUDs primarily work by suppressing the release of eggs, or by preventing sperm from reaching an egg. CNN has approached the American College of Obstetricians and Gynecologists for comment. 'Only a limited number of commodities have been approved for disposal. No HIV medications or condoms are being destroyed,' the spokesperson added. 'USAID avoided an additional $34.1 million in taxpayer costs by negotiating no-cost cancellations of pending orders placed under the Biden Administration.' Responding to media reports that the contraceptives were set to be transferred to a French medical waste facility to be destroyed by the end of July, a diplomatic source in France told CNN that the contraceptives were being handled by private entities and they had 'no information concerning any transfers,' as of Thursday last week. 'We firmly support the Belgian authorities' commitment to find a solution in order to prevent the destruction of these contraceptives, so that they may reach women and men around the world who need them and are waiting for them,' the diplomatic source added. 'Access to quality sexual and reproductive health services and products is both a human rights and a public health issue.' US Senator Jeanne Shaheen (D-NH) sent a staff member to the warehouse in Belgium as part of her effort to introduce legislation prohibiting 'the destruction of any such commodities unless all efforts to sell or donate them have been exhausted.' The staffer also found that the earliest expiration date for the contraceptives was 2027, with some of the supplies not expiring until 2031, meaning they could still be used for years to come. 'At a moment when the Trump administration has made devastating cuts to foreign assistance it is disappointing that the State Department would sign off on spending money to actually destroy paid-for commodities that would save lives and are waiting to be deployed,' Shaheen said in a statement. 'Food and family planning commodities are desperately needed in conflict affected countries, like Sudan and the Democratic Republic of Congo where famine is taking hold.' Belgian foreign ministry spokeswoman Florinda Baleci told CNN the country was 'exploring all possible avenues to prevent the destruction of these stocks, including their temporary relocation.' An organization called MSI Reproductive Choices said it and other funding partners had offered to pay for the shipping and repackaging of the USAID-branded supplies, but that the US government turned down the offer. 'We were not given a reason for why this offer was not accepted, but it became clear in conversations that it wouldn't be and that our efforts would be better spent finding alternative solutions to the contraception supplies gap,' said Grace Dunne, a spokeswoman for MSI, which works in 36 countries to provide reproductive healthcare, including abortion services, contraception and maternity care. In response to questions about the offer from CNN, the State Department highlighted the so-called 'Mexico City policy,' which 'prohibits providing certain assistance – directly or indirectly – to foreign nongovernmental organizations that perform or actively promote abortion as a method of family planning.' That policy, which opponents call the 'global gag rule,' prevents non-governmental organizations that provide abortions, give counseling about abortions or advocate for safe access to abortion from receiving US funding. The planned destruction of the contraceptives has sparked an outcry from other organizations, like Doctors Without Border (MSF), which raised concerns about contraceptive shortages in nations that were once reliant on supplies donated by USAID. 'In the communities served by MSF – whether impacted by conflict, disease outbreaks, natural and human-made disasters, or exclusion from health care – access to contraceptives is already constrained,' the organization said in a statement. 'Contexts that previously relied upon USAID funded contraceptive supplies are at a heightened risk of supply chain disruptions and stockouts.' 'MSF has seen firsthand the positive health benefits when women and girls can freely make their own health decisions by choosing to prevent or delay pregnancy – and the dangerous consequences when they cannot,' the chief executive of MSF USA, Avril Benoît, added. MSF also cited reports saying that more USAID-branded contraceptives are being housed in a warehouse in the United Arab Emirates, but the organization said the US government's plan for those supplies is unknown. A State Department spokesperson did not address a question about contraceptives warehoused in the UAE. CNN has reached out to the UAE government for comment. At the beginning of July, US Secretary of State Marco Rubio hailed the end of USAID, saying that future foreign assistance programs would align with administration policies and be administered by the State Department. The rapid dismantling of USAID, led by the Department of Government Efficiency (DOGE), has seen thousands of foreign assistance programs slashed, including many that focused on lifesaving work. A study published earlier this month by a leading medical journal, The Lancet, estimated that the USAID funding cuts could result in more than 14 million additional deaths by 2030. USAID funding was most likely to reduce mortality related to HIV/AIDS, followed by malaria, according to the study.
Business Upturn
3 hours ago
- Business Upturn
QuasarMD Unveils Advanced Full-Body Light Therapy Mat to Support Aging Wellness
CHINO, Calif., July 29, 2025 (GLOBE NEWSWIRE) — QuasarMD LLC, a leader in light-based wellness technologies, announces the launch of its Full-Body Light Therapy Mat , a clinically validated, non-invasive solution designed to address the evolving wellness needs of aging adults. The full-body mat features 2,052 high-efficiency LEDs delivering dual-wavelength therapy: 660nm red light for surface-level benefits, and 850nm near-infrared (NIR) for deep penetration. Both wavelengths are clinically proven to provide cellular-level therapeutic effects. Specifically designed for aging users, the system provides gentle yet effective relief for common age-related concerns including joint stiffness, muscle fatigue, circulation challenges, and chronic conditions like arthritis or back and knee pain. Designed with Aging in Mind 'Chronic pain, sleepless nights, and reduced mobility are common challenges as we age,' said a spokesperson for QuasarMD. 'Our full-body light therapy mat was specifically developed to help older adults restore their vitality through scientifically validated, non-invasive technology that integrates effortlessly into daily life.' The QuasarMD Full-Body Light Therapy Mat is FDA-cleared device meeting professional-grade standards. Its home operation couldn't be simpler – just lie down and press a button. Featuring an innovative wrap-around design, the mat cossets the body in comfort to ensure complete light exposure from head to toe. Users can easily customize their therapy experience by adjusting time, intensity, and pulse settings for each session. It has a multi-layered fabric design with an inner layer of TPU that enhances light retention, improving both durability and light efficiency. Additionally, it is waterproof and easy to clean, making it convenient for daily use by seniors and caregivers alike. The QuasarMD mat is more than just a health tool – it's a companion for active aging, offering a drug-free, non-invasive way to manage pain, inflammation, and fatigue. Its gentle warmth and therapeutic light not only ease physical discomfort but also enhance mental well-being, improve blood circulation, promote deep relaxation, and foster an enduring sense of vitality – all essential components of healthy aging. 'Today's aging population is more proactive about wellness than ever,' noted the spokesperson. 'Caregivers, wellness professionals, and older adults increasingly demand safe, science-backed solutions that are both effective and convenient for home use. The evidence supporting red and NIR light therapy is robust – and truly empowering.' 'That's why we've developed this solution: to help people naturally manage discomfort, improve sleep quality, and support long-term vitality – all without medications or invasive treatments.' About the Company QuasarMD LLC is a California-based wellness technology company specializing in FDA-cleared light therapy devices that blend clinical efficacy with user-friendly design. Dedicated to working on well-being through the life stages, it has kept innovating non-invasive devices that assist in recovery, wellness, and vigor through light. The Full-Body Light Therapy Mat is now available for purchase at the official QuasarMD shop and through Amazon . Media Contact:QuasarMD LLC Email: [email protected] Phone: 917-426-2860 Address: 15515 Dupont Avenue, Chino, CA 91710, USA Website:
